For example, expression of IFN-γ in serum and in the skin of psoriasis patients correlates with disease severity [37,40] whereas anti-IL-12p40 neutralising antibody (mAb) lessens disease activity in psoriasis patients [38]. This evidence concerns the gene IFNG and psoriasis.